RNA interference
Three stealth small interfering RNAs (siRNA) specific to ABCF1 (oligo IDs: HSS100039, HSS100040 and HSS 100041) and a control siRNA with matched GC content were purchased from Invitrogen. Transfection was performed with lipofectamine ® 2000 reagent (Invitrogen) according to instructions of the manufacturer. 100nmol/L of siRNA duplex was used for each transfection. Untreated cell-only control, cell plus lipofectamine andscrambled siRNA were included as control for each experiment.
RNA extraction and quantitative RT-PCR
Real-time quantitative reverse-transcription polymerase chain reaction was performed as previously described [3] . Primer probe sets used for RT-qPCR were detailed in Supplementary Table 1 . Relative expressions of genes were normalized with the 18s internal control and were presented as relative fold change.
Western blot analysis and immunohistochemical analysis
Total protein was extracted, separated by SDS-PAGE and transferred onto polyvinylidene difluoride membranes. Subsequently, the blots were blocked with 5% non-fat milk, followed by incubation with primary and HRP-conjugated secondary antibodies. β-actin (Sigma) was used for loading control. Proteins were visualized by the Enhanced Chemiluminescence Western Blotting Detection Kit (Amersham Bioscience, Amersham, UK). Immunohistochemical (IHC) staining on formalin-fixed, paraffin-embedded sections was performed using the Dako Envision Plus Kit (Dako, Carpinteria, CA, USA) according to manufacturer's instruction. Antibodies used were detailed in Supplementary Table 2 .
Flow cytometric analysis
For staining of cell surface expression of ABCF1, cells were detached by 5mM EDTA incubated with mouse anti-ABCF1 antibody (Abcam) or with equal amount of corresponding isotype control and then with FITC-conjugated goat anti-mouse secondary antibody. For staining of intracellular protein expression, cells were fixed by 4% PFA and permeabilized with ice-cold 0.1% saponin before incubation with primary antibody. Flow cytometric analysis was done by FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA) and data analysis by the FlowJo software (Tree Star, Inc., Ashland, OR, USA).
Immunofluorescence and confocal microscopy
For staining of ABCF1 protein at cell surface membrane, Hep3B and HepG2 cells cultured on 8-well chamber slides were stained with anti-ABCF1 antibody overnight at 4C in blocking solution (PBS/ 1% BSA) in the absence of detergent. Binding of secondary AlexaFluor 488-conjugated anti-mouse antibody was carried out at room temperature in dark for 1 hour. Cells were subsequently fixed in 4% formaldehyde/ PBS and permeabilized in PBS 0.25% Trixon-X 100 for 5 minutes, cells were stained for nucleus with Hoechst and coverslips were mounted in fluorescent mounting medium (Dako) or directly mounted with DAPI staining medium (Dako). Images were acquired with a Zeiss LSM 880 confocal laser scanning microscope.
Subcellular fractionation and cell surface protein isolation
Subcellular fractions of HCC cells were extracted using the ProteoExtractsubcellular proteome extraction kit (Merck, Darmstadt, Germany). Isolation of cell surface proteins by extracellular biotinylation was performed according to the manufacturer's instructions using the PierceCell Surface Protein Isolation Kit (ThermoScientific, Waltham, MA, USA).
Apoptosis assay and doxorubicin exclusion assay
For apoptosis assays, cells were treated with 60 µg/ml 5FU, 2 µg/ml or 1 µg/ml doxorubicin or 10 µg/ml cisplatin for 24 hours. Apoptosis was determined by cy5-Annexin V and 7-AAD staining (BD Biosciences) followed by flow cytometric analysis. For doxorubicin exclusion assay, cells were incubated with 0.1 µg/ml or 0.2 µg/ml doxorubicin for 4 hours. Intracellular doxorubicin accumulation was assessed by flow cytometry at FL2 spectrum. The drug efflux ability of HCC cells was determined as the doxorubicin (DOX) fluorescence index which was calculated as mean fluorescence intensity x percentage of doxorubicin-positive cells.
In vivo chemoresistance experiments
Nu/J nude mice of 6-7 weeks old were used to study the in vivo chemosensitivity of the cells. 3 × 10 6 Hep3B control or ABCF1 overexpressed cells were inoculated subcutaneously at the right dorsal region of the trunk of each animal. The mice were examined twice per week for the development of tumors. Tumor-bearing mice were randomized for intraperitoneal injection of saline (control group) or cisplatin (3.75 mg/ kg/ wk) for 3 weeks. Mice were then sacrificed at the fourth week and the tumor tissues were collected for further analysis. Each experimental group consisted 4-6 mice. The animals would be humanely sacrificed by overdose of isoflurane if they met the humane endpoint. Humane endpoint included large tumor burden (more than 2cm cube) or significant body weight loss (over 20%). The experimental procedures were approved by the Animal Experimental Ethics Committee at the Chinese University of Hong Kong.
Colony formation assay and spheroid formation assay HCC cells were seeded at a density of 500 cells/ well in 6-well plates and were allowed to grow for 14 days in culture medium containing 1% FBS with or without doxorubicin (Hep3B: 5 ng/ ml; HepG2: 10 ng/ ml). Colony formation was examined by a colorimetric assay using Giemsa stain which is then scanned for quantification. For spheroid formation assay, HCC cells were seeded in 24-well, ultra-low attachment plates at a density of 1000 cells/ well (for Hep3B) or 200 cells/ well (for HepG2) in standard sphere-forming medium as described previously [1] . After 9-14 days, images of spheroids were taken using an Axio Observer Z1 and the ZEN imaging software (Zeiss, Heidelberg, Germany) for counting. Quantification of colonies and spheroids were performed by Image J software (NIH, Bethesda, MD, USA) with a minimum diameter of 200 µm/ 100 µm for colonies (Hep3B/ HepG2) and 50 µm for spheroids.
Wound healing assay and transwell migration assay
Cells were seeded to form a confluent layer. A 'wound' was created by scraping the cell monolayer with a 200 µl pipette tip. Cell migration was observed in an Axio Observer Z1 (Zeiss) with live cell chamber and was monitored by time-lapse imaging using ZEN imaging software. Images were captured every 30 minutes for 72 hours. The area of the 'wound' at after every 12-hourinterval was quantified by the ZEN imaging software to determine the total area traveled by HCC cells after each interval. HepG2 cells were analyzed by transwell migration assays performed in 12-well plates chamber fitted with filter membrane of 8µm pores. The upper chamber was loaded with HCC cells in serum-free medium and the lower chamber was filled with serum-containing medium. After 24 hours of incubation, nonmigrating cells on the upper chamber was removed with cotton swabs. Migrated cells on the lower surface of the membrane were washed, fixed in methanol and stained with toluidine blue. The number of cells migrated were counted.
Whole transcriptome RNA sequencing (RNA-Seq) and functional pathway analysis Total RNA (2ug) was subjected to poly(A) enrichment for library preparation and RNA sequencing (Novogene Co. Ltd., Hong Kong) with standard protocol (Illumina Inc., San Diego CA, USA). With correction for the sequencing depth and transcript length, gene expression level was estimated as the quantification score FPKM (fragments per kilobase of transcript sequence per million fragments mapped) according to the abundance of transcripts mapped to specific exon. Functional classification of the differentially expressed genes (157 genes) in Gene Ontology (GO) terms for biological process and overrepresentation analysis for GO biological process were performed using the PANTHER platform (PANTHER 12.0, http://pantherdb.org/) [4] . Fisher's Exact test with FDR multiple test correction was used for the overrepresentation analysis. A list of 30, 262 genes (genes detected with FPKM>0) was used as reference gene list for the analysis.
Statistical analysis
Data were expressed as mean ± standard deviation (SD). Differences between groups were confirmed using two-tailed Student's t-test for comparison between two groups or one-way analysis for variance with Tukey's multiple comparison test for comparison between 3 or more groups, unless otherwise specified. P< 0.05 was considered statistically significant. GraphPad Prism (version 5.01, GraphPad Software, CA, USA) and SPSS (version 22.0, IBM Corp, NY, USA) were used for statistical analysis.
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Supplementary Fig. 1 . Upregulation of ABCF1 in HCCs associated with poor overall survival. (A) RNA-Seq data from the Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) datasets were analyzed using the GEPIA platform (http://gepia.cancer-pku.cn/detail.php?gene=) for the expression of ABCF1 in HCC tissues (n=369) and normal liver tissues (n= 160). Statistical analysis was conducted using one-way ANOVA, multiple testing adjusted q-value was obtained by the Benjamini and Hochberg false discovery rate (FDR) method. Differential expression was defined as genes with |log2FC|> 0.58 and q-value < 0.01. 
